SEC Form 4 filing activity
Scribe Therapeutics, Inc. (SCTX)
Code-P purchase filings sourced directly from SEC EDGAR. No predictions, no scores — just what was filed.
ClusterSignal displays factual data from public SEC filings. This is not investment advice and does not constitute a recommendation to buy or sell any security.
Filing activity increased
Multiple insiders filed purchases2026-07-23 – 2026-07-28
- Parrot David (Chief Financial Officer)1,333 sh @ $15.00
- Parrot David (Chief Financial Officer)1,333 sh @ $15.00
- Lucas Svetlana (Chief Business Officer)3,000 sh @ $15.00
- Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLC (Director, Director, Director)2,333,333 sh @ $15.00
- Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLC (Director, Director, Director)50,000 sh @ $22.31
- Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLC (Director, Director, Director)7,905 sh @ $18.25
3 distinct insiders, 6 qualifying purchases.
Full filing history
| Date | Insider | Shares | Price | Notes |
|---|---|---|---|---|
| 2026-07-28 | Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLCDirector, Director, Director | 7,905 sh | @ $18.25 | — |
| 2026-07-24 | Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLCDirector, Director, Director | 2,333,333 sh | @ $15.00 | — |
| 2026-07-24 | Aghazadeh Behzad, Avoro Capital Advisors LLC, Avoro Ventures LLCDirector, Director, Director | 50,000 sh | @ $22.31 | — |
| 2026-07-23 | Parrot DavidChief Financial Officer | 1,333 sh | @ $15.00 | — |
| 2026-07-23 | Parrot DavidChief Financial Officer | 1,333 sh | @ $15.00 | — |
| 2026-07-23 | Lucas SvetlanaChief Business Officer | 3,000 sh | @ $15.00 | — |